| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 02/06/2003 | WO2003010164A1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 02/06/2003 | WO2003010158A1 Novel compounds |
| 02/06/2003 | WO2003010153A1 N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses |
| 02/06/2003 | WO2003010143A1 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 02/06/2003 | WO2003010141A2 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure |
| 02/06/2003 | WO2003010140A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 02/06/2003 | WO2003010132A1 N-[(1-dimethylaminocycloalkyl)methyl]benzamide derivatives |
| 02/06/2003 | WO2003010130A1 Amino acid derivatives |
| 02/06/2003 | WO2003009807A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/06/2003 | US20030028034 Nematicidal pyrazoles |
| 02/06/2003 | US20030028026 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment |
| 02/06/2003 | US20030027963 Polymerizing a bis(hydrocarbylthio)methylaromatic compound to form a sulfide-substituted polyarylenevinylene and oxidizing the sulfide group |
| 02/06/2003 | US20030027862 Amino-and amido-diphenyl ethers |
| 02/06/2003 | US20030027849 2,2-difluoro-3-acylaminopropionic acid derivatives for treatment of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism and obesity. |
| 02/06/2003 | US20030027847 Carboxyformylacetamide derivatives for treatment of AIDS or ARC |
| 02/06/2003 | US20030027846 Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents |
| 02/06/2003 | US20030027840 Estrogen receptor modulators |
| 02/06/2003 | US20030027826 Useful for treating atherosclerosis and other coronary artery disease;reacting an amine compound with an epoxide derivative in presence of transition metal salt catalyst |
| 02/06/2003 | US20030027794 N-heterocyclic derivatives as NOS inhibitors |
| 02/06/2003 | CA2452259A1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 02/06/2003 | CA2452159A1 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/05/2003 | EP1280792A1 Method for producing benzo annelated heterocycles |
| 02/05/2003 | EP1280791A1 N-heteroarylmethyl-m-phenylenediamine derivative-containing dyes for keratin fibers and novel n-heteroarylmethyl-m-phenylenediamine derivatives |
| 02/05/2003 | EP1280764A2 Inhibitors of histone deacetylase |
| 02/05/2003 | EP1280757A2 New gamma selective retinoids |
| 02/05/2003 | EP1082121A4 Hiv integrase inhibitors |
| 02/05/2003 | EP0848706B1 Substituted benzene-fused heterocyclics as neurokinin antagonists |
| 02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 02/05/2003 | CN1394857A Compound used as antiproliferative agent and glycinamide ribonucleotide transformylase inhibitor |
| 02/05/2003 | CN1394855A Substituted heterocyclic compound |
| 02/05/2003 | CN1101008C Electrophotographic photoconductor and method for producing the same |
| 02/05/2003 | CN1100777C N-heterocyclic derivatives as NOS inhibitor |
| 02/05/2003 | CN1100535C Pharmaceutical agents for treatment of emesis |
| 02/04/2003 | US6515124 Dehydroamino acids |
| 02/04/2003 | US6515026 Potentiators of glutamate receptor function |
| 02/04/2003 | US6515023 Thrombin receptor antagonists |
| 02/04/2003 | US6515021 The compounds according to the invention have pronounced activity in the fields of cell differentiation and cell proliferation |
| 02/04/2003 | US6515002 Compounds and compositions for treating C1s-mediated diseases and conditions |
| 02/04/2003 | US6514967 Compound for preparing medicines for treating pathologies involving extracellular glutamate, and methods for obtaining same |
| 02/04/2003 | US6514434 Electro-optic chromophore bridge compounds and donor-bridge compounds for polymeric thin film waveguides |
| 01/31/2003 | WO2002012169A1 Amino diphenyl ethers and amido diphenyl ethers |
| 01/31/2003 | CA2417880A1 Amino diphenyl ethers and amido diphenyl ethers |
| 01/30/2003 | WO2003008404A2 Sulfonium salts as phtoinitiators for radiation curable systems |
| 01/30/2003 | WO2003008372A1 Diamine derivative, process for producing the same, and bactericide containing the same as active ingredient |
| 01/30/2003 | WO2003008371A1 Substituted 4-aminocyclohexanol derivatives |
| 01/30/2003 | WO2003008370A1 Substituted 4-aminocyclohexanols |
| 01/30/2003 | WO2003008362A1 Novel 3-aryl-2-hydroxy propanol derivatives and a process for their preparation |
| 01/30/2003 | WO2003002522A8 Peptide deformylase inhibitors |
| 01/30/2003 | WO2002070510A3 Amino dicarboxylic acid derivatives with pharmaceutical properties |
| 01/30/2003 | WO2002006267A3 Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin a |
| 01/30/2003 | US20030022935 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical agents |
| 01/30/2003 | US20030022865 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 01/29/2003 | EP1279691A1 Mono-, oligo- and poly-difluorovinyl-(hetero)arylenes, their synthesis and their use as charge transport materials |
| 01/29/2003 | EP1279690A1 Mono-oligo- and poly-3-substituted-4-fluorothiophenes and their use as charge transport materials |
| 01/29/2003 | EP1279689A2 Mono-, Oligo and Poly-3-(1,1-difluoroalkyl)thiophenes and their use as charge transport materials |
| 01/29/2003 | EP1279657A2 Process for preparing carbonyl compounds from alcohols |
| 01/29/2003 | EP1278741A1 Muscarinic agonists |
| 01/29/2003 | EP1278740A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 01/29/2003 | EP1278739A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor |
| 01/29/2003 | EP1278734A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| 01/29/2003 | EP1278723A2 P-(sulfonyl)-aryl and -heteroaryl amines |
| 01/29/2003 | EP1023283B1 Synthesis of 3-carbomethoxy-4,5-dimethylthiophene |
| 01/29/2003 | EP0835243B1 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
| 01/29/2003 | EP0832081B1 Bicyclic-aromatic compounds |
| 01/29/2003 | CN1394203A Piperidine and piperazine derivatives which function as 5-HT2A receptor antagonists |
| 01/29/2003 | CN1100055C Piperazine and piperidine compounds |
| 01/28/2003 | US6512122 Reacting a hexahalobenzene with a furan, thiophene, pyrrole, or cyclopropyl metallic derivative; hole transporting, green-light-emitting molecules |
| 01/28/2003 | US6512020 Oxime derivatives and the use thereof as latent acids |
| 01/28/2003 | US6512002 Methods of treatment for premature ejaculation in a male |
| 01/28/2003 | US6511990 Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 01/28/2003 | US6511980 For therapy of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel disorder |
| 01/28/2003 | US6511942 Animal husbandry, veterinary medicine |
| 01/23/2003 | WO2003007071A2 Novel nonlinear optical compounds and polymers |
| 01/23/2003 | WO2003007070A1 Novel nonlinear optical polymers incorporating amines |
| 01/23/2003 | WO2003007069A2 Novel nonlinear optical polymers |
| 01/23/2003 | WO2003006455A1 Pharmaceutical compounds with serotonin receptor activity |
| 01/23/2003 | WO2003006454A2 Heterocyclic carboxamides and their use as fungicides |
| 01/23/2003 | WO2003006447A2 Interaction inhibitors of tcf-4 with beta-catenin |
| 01/23/2003 | WO2003006443A2 2- 4-(naphtalin-2-yl)-thiazol-2-ylaminocarbonyl benzoic acid and 2- 4-(naphtalin-2-yl)-pyrimidin-2-ylaminocarbonyl benzoic acid and additional compounds serving as telomerase inhibitors for use in tumor therapy |
| 01/23/2003 | WO2003006435A1 Process for oxidation of alcohols |
| 01/23/2003 | WO2003006430A1 Taxol enhancer compounds |
| 01/23/2003 | WO2003006429A1 Synthesis of taxol enhancers |
| 01/23/2003 | WO2003006428A1 Taxol enhancer compounds |
| 01/23/2003 | WO2003006425A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 01/23/2003 | WO2003006424A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 01/23/2003 | WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | WO2003005823A2 Bromonitrothienyldioxans |
| 01/23/2003 | US20030018097 Light emitting polymer |
| 01/23/2003 | US20030018059 Antiinflammatory agents; antihistamines; antiallergens |
| 01/23/2003 | US20030018057 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
| 01/23/2003 | CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | CA2453415A1 Synthesis of taxol enhancers |
| 01/23/2003 | CA2453175A1 Interaction inhibitors of tcf-4 with beta-catenin |
| 01/23/2003 | CA2452491A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 01/22/2003 | EP1277751A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277749A1 2- and 2,5-substituted phenylketo enols |
| 01/22/2003 | EP1277736A1 Novel bicyclic compounds |
| 01/22/2003 | EP1277735A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277734A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277733A1 2- and 2,5-substituted phenylketo-enols |